Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02401503
Recruitment Status : Active, not recruiting
First Posted : March 27, 2015
Last Update Posted : October 17, 2018
Sponsor:
Collaborators:
Hoffmann-La Roche
AbbVie
Information provided by (Responsible Party):
German CLL Study Group